NanoViricides
NNVC
#10102
Rank
S$31.98 M
Marketcap
S$1.78
Share price
-4.20%
Change (1 day)
-11.06%
Change (1 year)

Market capitalization of NanoViricides (NNVC)

Market cap: S$31.98 Million

As of December 2025 NanoViricides has a market cap of S$31.98 Million. This makes NanoViricides the world's 10102th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of NanoViricides from 2007 to 2025

End of year Market Cap

Year Marketcap Change
2025S$31.98 M9.35%
2024S$29.25 M84.87%
2023S$15.82 M-8.41%
2022S$17.27 M-70.19%
2021S$57.96 M43.14%
2020S$40.49 M209.16%
2019S$13.09 M-31.03%
2018S$18.98 M-74.53%
2017S$74.55 M-17.29%
2016S$90.13 M-6.61%
2015S$96.51 M-52.52%
2014S$0.20 B-33.2%
2013S$0.30 B232.6%
2012S$91.5 M-22.44%
2011S$0.11 B-55.11%
2010S$0.26 B66.96%
2009S$0.15 B10.74%
2008S$0.14 B112.56%
2007S$66.86 M

End of Day market cap according to different sources

On Dec 8th, 2025 the market cap of NanoViricides was reported to be:

S$33.15 Million
by Nasdaq info icon info icon
S$33.38 Million
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
BioCryst Pharmaceuticals
BCRX
S$2.08 B 6,424.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
S$1.40 B 4,289.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
S$192.13 B 600,578.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
S$133.76 B 418,099.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
S$313.95 B 981,451.37%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
S$124.22 B 388,261.94%๐Ÿ‡ฌ๐Ÿ‡ง UK